Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment

Table 1 Results of IL-1α or IL-1β mRNA expression in several tumor cell lines evaluated by quantitative RT-PCR.

* Gene expression is expressed as copy number per 10⁵ copies of β-actin; copy number > 1,000/10⁵ copies β-actin is in boldface.

ISSN: 1479-5876